IL10 and metabolic dysfunction-associated steatotic liver disease: A study based on a high-fat diet-induced mouse model of NAFLD and primary KCs demonstrated that IL-4-activated M2 KCs could release IL-10 to promote apoptosis of M1 KCs thereby reducing liver inflammation and hepatocyte injury in NAFLD (99).